Nadolol (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Nadolol drug offered from Cadila Healthcare Limited. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
| NON-PROPRIETARY NAME: | Nadolol |
| SUBSTANCE NAME: | NADOLOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-08-08 |
| END MARKETING DATE: | 0000-00-00 |
Nadolol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nadolol from Cadila Healthcare Limited |
| LABELER NAME: | Cadila Healthcare Limited |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2017-08-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 70771-1089_a8d6ae8b-d94a-46a9-89a8-867e1c9e65a2 |
| PRODUCT NDC: | 70771-1089 |
| APPLICATION NUMBER: | ANDA207761 |
Other NADOLOL Pharmaceutical Manufacturers / Labelers:
